Black Diamond Therapeutics

Black Diamond Therapeutics discovers and develops small molecule therapies for precision oncology. It focuses on allosteric mutations in kinases related to cancer, with a lead product candidate targeting non-canonical ErbB kinase mutations.

Fang Ni Ph.D

Chief Business Officer and CFO

1 past transactions

Launchpad Therapeutics

Series A in 2022
Launchpad Therapeutics is an antibody-focused precision oncology company.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.